← Back to Search

Educational Media Interventions for Cancer (ADELANTE Trial)

N/A

Recruiting

Led By Lisa Kachnic, MD

Research Sponsored by Columbia University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patients with non-metastatic prostate or breast cancer

Karnofsky performance status 70 or greater

Must not have

RT for sites other than breast or prostate

Prior RT

Timeline

Screening 3 weeks

Treatment Varies

Follow Up following completion of rt (4-6 weeks from enrollment for breast cancer, 4-9 weeks for prostate cancer), for up to 5 years

Awards & highlights

No Placebo-Only Group

Summary

This trial is studying how well educational media interventions work in preparing Latinx Spanish-speaking patients for radiation therapy for breast or prostate cancer and in fostering receptivity to and informed decision-making around cancer clinical trial participation.

Who is the study for?

This trial is for Latinx Spanish-speaking individuals with a confirmed diagnosis of non-metastatic breast or prostate cancer. They must have a Karnofsky performance status of 70 or above, indicating they are able to care for themselves. Women who can bear children need pregnancy tests as per guidelines. Participants should be planning to receive or currently undergoing curative radiation therapy and must consult using a certified interpreter.

What is being tested?

The study is testing educational media interventions designed to help Latinx patients understand radiation therapy for breast or prostate cancer and encourage informed participation in clinical trials. It includes an audiovisual education program on radiation therapy and brochures from ASTRO and NCI about cancer treatments and research studies.

What are the potential side effects?

Since this trial focuses on educational materials rather than medical treatments, there are no direct side effects related to drugs or therapies being tested. However, participants may experience emotional responses to the information provided.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My cancer has not spread beyond my prostate or breast.

Select...

I am able to care for myself but cannot do normal activities without help.

Select...

I have been diagnosed with prostate or breast cancer through a tissue examination.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have received radiation therapy for areas other than my breast or prostate.

Select...

I have previously undergone radiation therapy.

Select...

My cancer has spread to other parts of my body.

Select...

I am deaf and/or blind in both ears/eyes.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ following completion of rt (4-6 weeks from enrollment for breast cancer, 4-9 weeks for prostate cancer), for up to 5 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~following completion of rt (4-6 weeks from enrollment for breast cancer, 4-9 weeks for prostate cancer), for up to 5 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and following completion of rt (4-6 weeks from enrollment for breast cancer, 4-9 weeks for prostate cancer), for up to 5 years for reporting.